Structure–activity studies of phenanthroindolizidine alkaloids as potential antitumor agents
- 1 August 2007
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (15), 4338-4342
- https://doi.org/10.1016/j.bmcl.2007.05.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inhibition of cell growth and nuclear factor-κB activity in pancreatic cancer cell lines by a tylophorine analogue, DCB-3503Molecular Cancer Therapeutics, 2006
- Abrogation of skin disease in LUPUS‐prone MRL/FASlpr mice by means of a novel tylophorine analogArthritis & Rheumatism, 2006
- Effects of a novel tylophorine analog on collagen‐induced arthritis through inhibition of the innate immune responseArthritis & Rheumatism, 2006
- Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancerInternational Journal of Gynecologic Cancer, 2005
- Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene–Expressing Pancreatic Tumor Cell LineClinical Cancer Research, 2005
- Cytotoxic Alkaloids from the Roots ofTylophora atrofolliculataPlanta Medica, 2004
- A short synthesis of (S)-(+)-tylophorineThe Journal of Organic Chemistry, 1987
- Multiple nuclear factors interact with the immunoglobulin enhancer sequencesCell, 1986
- Amino acids as chiral educts for asymmetric products. Chirally specific syntheses of tylophorine and cryptopleurineThe Journal of Organic Chemistry, 1983
- Inhibition of protein synthesis in ehrlich ascites-tumour cells by the phenanthrene alkaloids tylophorine, tylocrebrine and cryptopleurineBiochemical and Biophysical Research Communications, 1968